Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety

Oaknin, Ana; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Dean, Andrew; Colombo, Nicoletta; Weberpals, Johanne I.; Clamp, Andrew R.; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Amenedo Gancedo, Margarita; Fong, Peter C.; Goh, Jeffrey C.; O’Malley, David M.; Armstrong, Deborah K.; Banerjee, Susana; García‐Donas, Jesus; Swisher, Elizabeth M.; Cameron, Terri; Maloney, Lara; Goble, Sandra; Ledermann, Jonathan A.; Coleman, Robert L.

Published in

Wiley Open Access, Cancer Medicine, 20(10), p. 7162-7173, 2021

DOI: 10.1002/cam4.4260

Tools

Export citation

Search in Google Scholar

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety

Journal article published in 2021 by Ana Oaknin, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals

, Andrew R. Clamp, Giovanni Scambia

, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum‐based regimen and disease at baseline on efficacy and safety